Insights into improving the radiosensitivity of Mammary cancer cells: Metformin, the widely drug in the treatment of NIDDM, inhibits UBQLN1-mediated autophagy and radio resisitance pathway via up regulation of its target gene, 04.55 am., 2/August/2014